14
Jul 2026
Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.
Stay Informed!
14
Jul 2026
Ultrasensitive biosensor detects early-stage liver fibrosis using small amount of blood
A research team led by Professor Jinsung Park of the Department of Biomechatronic Engineering at Sungkyunkwan University(SKKU), working jointly with Professor Pil-Soo Sung of the College of Medicine at the Catholic University of Korea and Professor Si-Hyun Bae, President of Eunpyeong St. Mary's Hospital, has developed an ultrasensitive electrochemical biosensor capable of accurately detecting "early-stage liver fibrosis"—a condition in which the liver progressively hardens—using only a small amount of blood.
14
Jul 2026
New plant-based wound dressing delivers antibiotics to fight infections
A new dressing made from plant-based materials can deliver antibiotics directly to wounds during critical early stages of infection, according to researchers from the University of Bath.
14
Jul 2026
Study reports a counterintuitive new approach to treating mesothelioma
Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year.
14
Jul 2026
Researchers propose simple finger prick test to track metabolic health
Researchers writing in Frontiers in Science propose using simple tests to track metabolic health in non-communicable diseases, which cause three in four deaths worldwide.
14
Jul 2026
Face recognition declines with age may lie in how your eyes move
Aging-related declines in face recognition are linked to reduced eye movement consistency, emphasizing the role of cognitive processes in visual routines.
14
Jul 2026
WHO validates El Salvador for eliminating trachoma as public health problem
The World Health Organization (WHO) has validated El Salvador as having eliminated trachoma as a public health problem. Trachoma is the world's leading infectious cause of blindness.
14
Jul 2026
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise navigation and delivery to the brain, today announced a partnership to support the targeted delivery of EpilepsyGTx's lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).
14
Jul 2026
Unreliable datasets are shaping clinical prediction models
This research assesses data provenance in widely used health datasets, revealing flaws that could undermine clinical prediction models and patient care.
14
Jul 2026
Semaglutide dose may matter more than weight loss for heart health
The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging existing treatment assumptions.
